Trellus Health plc provides resilience-driven health solutions for the management of chronic conditions, focusing primarily on inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis. The company utilizes its proprietary technology platform, Trellus Elevate®, to deliver personalized, condition-agnostic programs that enhance patient engagement, improve treatment adherence, and reduce healthcare costs. Trellus Health partners with pharmaceutical companies, clinical trial organizations, large employers, and health plans to commercialize its digital chronic condition management solutions, which are based on the scientifically validated GRITT™ methodology developed in collaboration with the Mount Sinai IBD Center.